| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| DHK23201B |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
1.0 mg |
$1,715.00
|
 |
BUY
|
| DHK23201A |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHB54003A |
Research Grade Anti-Human TNFSF15/TL1A (PRA023) |
100 µg |
$405.00
|
|
BUY
|
| DHB54003B |
Research Grade Anti-Human TNFSF15/TL1A (PRA023) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHG62603A |
Research Grade Anti-Human TPBG/5T4 (ASN004) |
100 ug |
$475.00
|
|
BUY
|
| DHG62603B |
Research Grade Anti-Human TPBG/5T4 (ASN004) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV02813A |
Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV90) |
100 µg |
$475.00
|
|
BUY
|
| DVV02813B |
Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV90) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV02817A |
Research Grade Anti-RSV F/Fusion glycoprotein F0 (RSV7.10) |
100 µg |
$475.00
|
|
BUY
|
| DVV02817B |
Research Grade Anti-RSV F/Fusion glycoprotein F0 (RSV7.10) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00336B |
Research Grade Anti-SARS-CoV-2 S2 subunit FP Neutralizing (COV44-79) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00336A |
Research Grade Anti-SARS-CoV-2 S2 subunit FP Neutralizing (COV44-79) mAb |
100 µg |
$475.00
|
|
BUY
|
| DVV00503B |
Research Grade Anti-SARS-CoV-2 S2 subunit SH Neutralizing (WS6) mAb |
1.0 mg |
$1,485.00
|
|
BUY
|
| DVV00503A |
Research Grade Anti-SARS-CoV-2 S2 subunit SH Neutralizing (WS6) mAb |
100 µg |
$405.00
|
|
BUY
|
| DVV00332A |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
100 µg |
$475.00
|
|
BUY
|
| DVV00332B |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DHD47902A |
Research Grade Aprutumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47902B |
Research Grade Aprutumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ64002B |
Research Grade Azintuxizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ64002A |
Research Grade Azintuxizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02203A |
Research Grade Balstilimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02203B |
Research Grade Balstilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47901B |
Research Grade Bemarituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47901A |
Research Grade Bemarituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210A |
Research Grade Budigalimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210B |
Research Grade Budigalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02211B |
Research Grade Camrelizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02211A |
Research Grade Camrelizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02204B |
Research Grade Cetrelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02204A |
Research Grade Cetrelimab |
100 ug |
$380.00
|
|
BUY
|
| DHD17401A |
Research Grade Citatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17401B |
Research Grade Citatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603B |
Research Grade Disitamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603A |
Research Grade Disitamab |
100 ug |
$380.00
|
|
BUY
|
| DFJ05001A |
Research Grade Dovanvetmab |
100 ug |
$420.00
|
|
BUY
|
| DFJ05001B |
Research Grade Dovanvetmab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD17403A |
Research Grade Edrecolomab |
100 ug |
$380.00
|
|
BUY
|
| DHD17403B |
Research Grade Edrecolomab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ04001A |
Research Grade Enoblituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ04001B |
Research Grade Enoblituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09608A |
Research Grade Ertumaxomab |
100 ug |
$560.00
|
|
BUY
|
| DHC09608B |
Research Grade Ertumaxomab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DVV00306A |
Research Grade Etesevimab |
100 ug |
$475.00
|
|
BUY
|
| DVV00306B |
Research Grade Etesevimab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHH02220A |
Research Grade Ezabenlimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02220B |
Research Grade Ezabenlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC19529A |
Research Grade Fabrazyme/Agalsidase Beta |
100 ug |
$540.00
|
|
BUY
|
| DHC19529B |
Research Grade Fabrazyme/Agalsidase Beta |
1.0 mg |
$1,970.00
|
|
BUY
|
| DHJ92102A |
Research Grade Feladilimab |
100 ug |
$380.00
|
|
BUY
|
| DHJ92102B |
Research Grade Feladilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09606A |
Research Grade Gancotamab |
100 ug |
$490.00
|
|
BUY
|
| DHC09606B |
Research Grade Gancotamab |
1.0 mg |
$1,790.00
|
|
BUY
|
| DVV03701B |
Research Grade Lenvervimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV03701A |
Research Grade Lenvervimab |
100 ug |
$420.00
|
|
BUY
|
| DHH02212B |
Research Grade Lodapolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02212A |
Research Grade Lodapolimab |
100 ug |
$380.00
|
|
BUY
|
| DHD10806A |
Research Grade Loncastuximab |
100 ug |
$420.00
|
|
BUY
|
| DHD10806B |
Research Grade Loncastuximab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHE16602B |
Research Grade Olinvacimab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHE16602A |
Research Grade Olinvacimab |
100 ug |
$430.00
|
|
BUY
|
| DHL04002B |
Research Grade Omburtamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ04002B |
Research Grade Omburtamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ04002A |
Research Grade Omburtamab |
100 ug |
$380.00
|
|
BUY
|
| DHD17405B |
Research Grade Oportuzumab |
1.0 mg |
$1,790.00
|
|
BUY
|
| DHD17405A |
Research Grade Oportuzumab |
100 ug |
$490.00
|
|
BUY
|
| DHH02216A |
Research Grade Pidilizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02216B |
Research Grade Pidilizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ48301B |
Research Grade Ponsegromab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ48301A |
Research Grade Ponsegromab |
100 ug |
$420.00
|
|
BUY
|
| DHH02217A |
Research Grade Prolgolimab |
100 ug |
$430.00
|
|
BUY
|
| DHH02217B |
Research Grade Prolgolimab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHH02218B |
Research Grade Retifanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02218A |
Research Grade Retifanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHD18001A |
Research Grade Rolinsatamab |
100 ug |
$420.00
|
|
BUY
|
| DHD18001B |
Research Grade Rolinsatamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC09612B |
Research Grade Runimotamab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHC09612A |
Research Grade Runimotamab |
100 ug |
$615.00
|
|
BUY
|
| DHH02219B |
Research Grade Sasanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02219A |
Research Grade Sasanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02213B |
Research Grade Serplulimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02213A |
Research Grade Serplulimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02207A |
Research Grade Sintilimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02207B |
Research Grade Sintilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17407B |
Research Grade Solitomab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHD17407A |
Research Grade Solitomab |
100 ug |
$560.00
|
|
BUY
|
| DHC33102B |
Research Grade Sotatercept |
1.0 mg |
$1,970.00
|
|
BUY
|
| DHC33102A |
Research Grade Sotatercept |
100 ug |
$540.00
|
|
BUY
|
| DHH02214A |
Research Grade Spartalizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02214B |
Research Grade Spartalizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH72406A |
Research Grade Tamgiblimab |
100 ug |
$420.00
|
|
BUY
|
| DHH72406B |
Research Grade Tamgiblimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHE16604A |
Research Grade Tanibirumab |
100 ug |
$430.00
|
|
BUY
|
| DHE16604B |
Research Grade Tanibirumab |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHC27706A |
Research Grade Tebentafusp |
100 ug |
$540.00
|
|
BUY
|
| DHF92402A |
Research Grade Teclistamab |
100 ug |
$615.00
|
|
BUY
|
| DHF92402B |
Research Grade Teclistamab |
1.0 mg |
$2,235.00
|
|
BUY
|
